Positron Emission Tomography (PET) is a significant advance in cancer imaging with great
potential for optimizing radiation therapy (RT) treatment planning and thereby improving …

Target volume delineation of lung cancer is well known to be prone to large inter-observer
variability. The advent of PET/CT devices, with co-registered functional and anatomical data …

PURPOSE: Target-volume delineation for radiation treatment to the head and neck area
traditionally is based on physical examination, computed tomography (CT), and magnetic …

Radiotherapy target volume definition is a critical step in the radiotherapy treatment planning
process for all tumour sites. New technology may improve the identification of tumour from …

Multimodality imaging information is regularly used now in radiotherapy treatment planning
for cancer patients. The authors are investigating methods to take advantage of all the …

Introduction Since their introduction in 2001, PET/CT systems have gained wide acceptance
primarily due to their inherent ability to combine functional and structural information about …

Multimodality image registration and fusion have a key role in routine diagnosis, staging,
restaging, and the assessment of response to treatment, surgery, and radiotherapy planning …

New high-precision radiotherapy (RT) techniques, such as intensity-modulated radiation
therapy (IMRT) or hadrontherapy, allow better dose distribution within the target and spare a …

PURPOSE: To determine the impact of 18F-fluorodeoxyglucose positron emission
tomography (PET) in radiotherapy target delineation and patient management for head and …

The role of positron emission tomography (PET) during the past decade has evolved rapidly
from that of a pure research tool to a methodology of enormous clinical potential. 18F …